Global Clinical Microbiology Market by Application (STD, UTI, Respiratory, Periodontal, Bloodstream, Gastrointestinal) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global clinical microbiology market was valued at USD 9.1 million in 2016. It is forecast to grow at 6.7% CAGR over the forecast period. Market growth is driven by the increasing incidence of infectious diseases.

Clinical tests are the most common way to diagnose infectious diseases. The Centers for Disease Control and Prevention reported that there were approximately 9,421 new cases in the United States of tuberculosis and 51,455 new salmonella cases. 33,461 Lyme disease cases were also added to the list. 433 cases of meningococcal diseases were also registered in the U.S.

According to the American Cancer Society in 2017, around 1,688,780 cases of new cancers were reported in the United States. Market growth will be boosted by the high number of diseases in which clinical tests are used to diagnose them. Sudden epidemics of Zika, Ebola and other contagious diseases are contributing to an increase in the prevalence of infectious disease.

According to a Journal of Clinical Microbiology article, there is a shortage of skilled and trained professionals in medical and microbiological laboratory for processing and interpreting specimens and samples. In the U.S., there has been an accelerated decline in medical laboratory training programs. This is also evident in the graduation rates of such students.

In developing countries, which are experiencing a rapid increase in demand for skilled workers, the shortage of graduates and programs to train them is a problem. The entry of automated platforms on the market will replace manual-operated traditional platforms in the future, which will reduce the impact of the shortage of skilled professionals.

Product Insights

The largest share of revenue in the global clinical microbiology industry was accounted by the agents. This segment includes solutions, primers and master mixes as well as kits that are used in various diagnostic assays. The largest share of revenue is currently attributed to reagents, where more than 60% can be attributed to repeat purchases driven by the need for new reagents for different tests.

This segment will continue to dominate the forecast period. The segment will be driven by factors such as the higher cost of specialized kit and the constant repeat purchase. There are rising investments in research-and-development (R&D) in the market. The majority of therapeutic and analytical research projects require reagents or chemicals. This drives penetration.

Incubators, gram strainers and bacterial colony counters are all part of laboratory instruments. They also include autoclave sterilizers and petri dish fillers. With more than 30% of the market share, automated culture systems dominated global laboratory instruments in 2016.

Instruments used in microbiology analysis include instruments that are used in molecular diagnostics and mass spectrometry. Due to their wider application and growing demand, microscopes accounted for the largest percentage. The fastest expected growth rate for the molecular diagnostic instrument segment is however, over the forecast period. This is due to the increasing importance of molecular diagnostics in early detection and treatment of cancer and other infectious diseases.

Application Insights

The rapid rise in respiratory diseases is due to increasing levels of pollution and industrialization. The easy transmission of contagious pathogens makes respiratory diseases more common than any other infections. This segment is expected to grow significantly over the forecast period. In developed and developing countries, the prevalence of infectious diseases are high.

A few studies published in the Journal of the American Medical Association have shown that chronic respiratory disease was responsible for approximately 1 in 15 deaths in 2015. These diseases were responsible for approximately USD 132 billion in healthcare expenditures in 2013. The most common diagnostic tools for respiratory disease are bronchoscopy, blood tests and biopsy. Market growth is being accelerated by the rising incidence of chronic respiratory illnesses.

Regional Insights

In 2016, North America was the country with the highest revenue share, closely followed by Europe. The adoption of advanced diagnostic techniques is being encouraged by the U.S.'s highly developed healthcare and industrial sectors. A stringent regulatory framework, as well as the presence of major players, are helping to boost regional market growth.

Asia Pacific will be the fastest-growing region between 2016 and 2024. Japan is a country with the most technological advancements and highest usage of microbial testing in various applications. China is another important market that contributes to regional growth.

The boom in medical tourism is expected to increase demand for microbial diagnostics and monitoring tests in Asian countries like India, China and Thailand. A combination of high-quality manufacturing infrastructure and skilled labor at an affordable price has led to major manufacturers of medical devices and pharmaceuticals moving to Asia. This is driving regional market expansion.

Clinical Microbiology Market Share insights

Bruker Corporation, Cepheid Inc., bioMerieux S.A. and Cepheid Inc. are the main players in this market. Becton Dickinson & Company, Cepheid Inc., and Danaher Corporation are some of the other prominent players in the market. The introduction of automated systems and innovative designs will increase competition and change the market dynamics over time.

Market Report Scope for Clinical Microbiology

The Report Covers Certain Segments

This report predicts revenue growth at the global, regional and country level. It also provides analysis on industry trends and potential opportunities for each sub-segment from 2014 through 2025. Grand View Research segmented the global market for clinical microbiology on the basis product, region, and application.

• Product Outlook (Revenue USD Million, 2014-2025)

  • Laboratory Instruments

    • Incubators

    • Gram Stainers

    • Bacterial Colony Counters

    • Autoclave Sterilizers

    • Petri Dish Fillers

  • Automated Culture Systems

    • Microbiology Analyzers

    • Molecular Diagnostic Instruments

    • Microscopes

    • Mass Spectrometers

  • Reagents

• App Outlook (Revenue USD Million, 2014-2025)

  • Respiratory Diseases

  • Bloodstream Infections

  • Gastrointestinal Diseases

  • Sexually Transmitted Diseases

  • Infections of the Urinary Tract

  • Periodontal Diseases

  • Other diseases

• Regional Outlook (Revenue USD Million, 2014-2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

  • Asia Pacific

    • China

    • India

    • Japan

  • Latin America

    • Mexico

    • Brazil

  • Middle East & Africa

    • South Africa

These are the most frequently asked questions about this report

b. Global clinical microbiology market was valued at USD 11.6 billion in 2019, and is projected to grow to USD 12.4 billion by 2020.

b. Global clinical microbiology markets are expected to expand at 6.7% compound annual growth rate between 2017 and 2025, reaching USD 16.7 billion in 2025.

b. With a market share of 40.3%, North America was the dominant player in clinical microbiology. This can be attributed to the U.S.'s highly developed healthcare and industrial sectors, which are driving the adoption of advanced clinical diagnostic methods.

b. BioMerieux S.A., Cepheid Inc., Danaher Corporation, Bruker Corporation; Becton Dickinson & Company (Hologic Inc.); Roche Diagnostics; Alere Inc. are some of the key players in clinical microbiology.

b. b.

Up Market Research published a new report titled “Clinical Microbiology Market research report which is segmented by Application (STD, UTI, Respiratory, Periodontal, Bloodstream, Gastrointestinal), By Players/Companies Incubators, Bacterial Colony Counters, Gram Stainers, Petri Dish Fillers, Product Outlook (Revenue USD Million 2014 - 2025)Laboratory InstrumentsIncubatorsGram StainersBacterial Colony CountersAutoclave SterilizersPetri Dish Fillers, Laboratory InstrumentsIncubatorsGram StainersBacterial Colony CountersAutoclave SterilizersPetri Dish Fillers, Autoclave Sterilizers”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Clinical Microbiology Market Report Segments:

The market is segmented by Application (STD, UTI, Respiratory, Periodontal, Bloodstream, Gastrointestinal).

Clinical Microbiology Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Clinical Microbiology Market

Overview of the regional outlook of the Clinical Microbiology Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Clinical Microbiology Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Clinical Microbiology Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. STD

                2. UTI

                3. Respiratory

                4. Periodontal

                5. Bloodstream

                6. Gastrointestinal

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Clinical Microbiology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Clinical Microbiology Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.